W. Ben Deibler
Directeur/Membre du Conseil chez OcuCure Therapeutics, Inc.
Profil
W.
Ben Deibler is currently a Director at OcuCure Therapeutics, Inc. He previously worked as a Principal at Johnson & Johnson and as a Vice President-Business Development at Johnson & Johnson Vision Care, Inc. Deibler received an undergraduate degree from Drexel University and an MBA from Fairleigh Dickinson University.
Postes actifs de W. Ben Deibler
| Sociétés | Poste | Début |
|---|---|---|
OcuCure Therapeutics, Inc.
 OcuCure Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology OcuCure Therapeutics, Inc. discovers and develops drugs. It develops technologies to reduce and prevent vision loss caused by eye diseases. The firm provides drugs for treatment of age-related macular degeneration that inhibit new blood vessels from sprouting and causes regression of partially grown blood vessels. The company was founded in 2005 and is headquartered in Roanoke, VA. | Directeur/Membre du Conseil | - |
Anciens postes connus de W. Ben Deibler
| Sociétés | Poste | Fin |
|---|---|---|
| JOHNSON & JOHNSON | Corporate Officer/Principal | - |
Johnson & Johnson Vision Care, Inc.
 Johnson & Johnson Vision Care, Inc. Electronic ComponentsElectronic Technology Johnson & Johnson Vision Care, Inc. manufactures and markets vision care products. The company was founded on March 07, 1962 and is headquartered in Jacksonville, FL. | Corporate Officer/Principal | - |
Formation de W. Ben Deibler
| Drexel University | Undergraduate Degree |
| Fairleigh Dickinson University | Masters Business Admin |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| JOHNSON & JOHNSON | Health Technology |
| Entreprise privées | 2 |
|---|---|
OcuCure Therapeutics, Inc.
OcuCure Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology OcuCure Therapeutics, Inc. discovers and develops drugs. It develops technologies to reduce and prevent vision loss caused by eye diseases. The firm provides drugs for treatment of age-related macular degeneration that inhibit new blood vessels from sprouting and causes regression of partially grown blood vessels. The company was founded in 2005 and is headquartered in Roanoke, VA. | Health Technology |
Johnson & Johnson Vision Care, Inc.
Johnson & Johnson Vision Care, Inc. Electronic ComponentsElectronic Technology Johnson & Johnson Vision Care, Inc. manufactures and markets vision care products. The company was founded on March 07, 1962 and is headquartered in Jacksonville, FL. | Electronic Technology |
